Recce Pharmaceuticals Ltd.ASX: RCE

Phase I Clinical Trial R327 Advances to 4000mg

May 20, 2022 at 4:14 AM UTC · Issued by Recce Pharmaceuticals Ltd.

Recce Ltd has released a press release.

View Attachment